由Hippo Pathway调节瘤免疫微环境:对癌症免疫疗法的影响
Chang Liu1, Yang Song2, DeMing Li3
1Department of Radiation Oncology, the First Hospital of China Medical University, Shenyang, Liaoning Province, PR China.
International immunopharmacology
|July 2, 2023
概括
河马通路调节瘤免疫微环境 (TIME) 中的免疫细胞,影响癌症的进展和治疗. 了解这种相互作用为癌症提供了新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 瘤免疫微环境 (TIME) 是一个复杂的生态系统,对癌症的进展和治疗反应至关重要.
- 与瘤相关的免疫细胞是TIME中的关键调节者,影响免疫反应和治疗疗效.
- 河马通路是一个关键的信号通路,涉及到TIME调节和癌症进展.
研究的目的:
- 为了回顾河马通道在"时代"中的作用.
- 探索其与各种免疫细胞 (T细胞,巨细胞,B细胞,MDSCs,树突细胞) 的相互作用.
- 讨论其对PD-L1表达的影响及其作为治疗点的潜力.
主要方法:
- 文献综述,重点关注河马通路在 TIME 中的功能.
- 分析Hippo路径对免疫细胞活动的调节.
- 探索Hippo路径对癌症生物学和治疗的影响.
主要成果:
- 河马通路调节T细胞功能,巨细胞极化,B细胞分化,骨髓衍生抑制细胞 (MDSC) 活动和树突细胞反应.
- 该途径影响淋巴细胞中的PD-L1表达,这是癌症免疫疗法的关键标.
- 阐明Hippo路径-TIME交叉对理解癌症的发展和治疗至关重要.
结论:
- 河马通路是 TIME 内的免疫细胞功能的重要调节者.
- 准Hippo通路为新的癌症治疗策略提供了潜力.
- 需要进一步的研究来克服理解上下文依赖效应和识别预测生物标志物的挑战.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.9K
09:01Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
448
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
